The 5-Second Trick For Excipients and APIs
“The existing problem has uncovered some structural weaknesses within the EU’s medicines provide chain as well as a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She recommended that supply chain challenges be tackled in an EU pharm